Aminoquinoline derivatives and their use as adenosine A3 ligands

Details for Australian Patent Application No. 2004259127 (hide)

Owner Sanofi-Aventis

Inventors Batori, Sandor; Urban-Szabo, Katalin; Vargane Szeredi, Judit; Timari, Geza; Gerber, Katalin; Mikus, Endre; Boer, Kinga; Kapui, Zoltan; Finet, Michel; Aranyi, Peter

Agent Watermark

Pub. Number AU-B-2004259127

PCT Pub. Number WO2005/009969

Priority P 0401467 21.07.04 HU; P 0401468 21.07.04 HU; P 0302440 31.07.03 HU

Filing date 23 July 2004

Wipo publication date 3 February 2005

Acceptance publication date 28 May 2009

International Classifications

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07C 229/50 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07D 215/48 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009969 Priority application(s): WO2005/009969

28 May 2009 Application Accepted

  Published as AU-B-2004259127

24 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259133-Nicotinamide derivatives useful as PDE4 inhibitors

2004259112-Aryl heteroaromatic products, compositions comprising the same and use thereof